EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Adeno-Associated Virus Vectors in Retinal Gene Therapy: Challenges, Innovations, and Future Directions

Jiayu Huang, Jiajun Li, Xiangzhong Xu, Keran Li

Biomolecules · 2025

DOI: 10.3390/biom15070940 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Biomolecules, 2025. Verfasst von Jiayu Huang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, The Affiliated Eye Hospital of Nanjing Medical University, 138 Hanzhong Road, Nanjing 210029, China. Hauptthemen laut MEDLINE: Dependovirus, Genetic Therapy, Genetic Vectors, Retinal Diseases. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 143 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: 2023 Langshijie • Muguangming Young and Middle-Aged Ophthalmology Scientific Research Project, Nanjing Medical Science and Technology Development Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Adeno-associated virus (AAV) vectors have emerged as the leading platform for retinal gene therapy due to their favorable safety profile, low immunogenicity, and ability to mediate long-term transgene expression within the immune-privileged ocular environment. By integrating diverse strategies such as gene augmentation and gene editing, AAV-based therapies have demonstrated considerable promise in treating both inherited and acquired retinal disorders. However, their clinical translation remains limited by several key challenges, including restricted packaging capacity, suboptimal transduction efficiency, the risk of gene therapy-associated uveitis, and broader societal concerns such as disease burden and ethical oversight. This review summarizes recent advances aimed at overcoming these barriers, with a particular focus on delivery route-specific disease applicability, multi-vector systems, and capsid engineering approaches to enhance payload capacity, targeting specificity, and biosafety. By synthesizing these developments, we propose a conceptual and technical framework for a more efficient, safer, and broadly applicable AAV platform to accelerate clinical adoption in retinal gene therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DependovirusGenetic TherapyGenetic VectorsRetinal DiseasesRetinaHumansAnimalsGene Transfer Techniques

Stichwörter der Autor:innen

adeno-associated virus (AAV)capsid engineeringgene therapy-associated uveitislarge-gene deliveryretinal gene therapy

Autor:innen und Institutionen

  • Department of Ophthalmology, The Affiliated Eye Hospital of Nanjing Medical University, 138 Hanzhong Road, Nanjing 210029, China.
  • The Fourth School of Clinical Medicine, Nanjing Medical University, Nanjing 210029, China.

Förderung

  • 2023 Langshijie • Muguangming Young and Middle-Aged Ophthalmology Scientific Research Project
  • Nanjing Medical Science and Technology Development Project

Zitieren

APA

Huang, J., Li, J., Xu, X., & Li, K. (2025). Adeno-Associated Virus Vectors in Retinal Gene Therapy: Challenges, Innovations, and Future Directions. Biomolecules. https://doi.org/10.3390/biom15070940

Vancouver

Huang J, Li J, Xu X, Li K. Adeno-Associated Virus Vectors in Retinal Gene Therapy: Challenges, Innovations, and Future Directions. Biomolecules. 2025. doi:10.3390/biom15070940

BibTeX
@article{Huang2025,
  author = {Huang, Jiayu and Li, Jiajun and Xu, Xiangzhong and Li, Keran},
  title = {Adeno-Associated Virus Vectors in Retinal Gene Therapy: Challenges, Innovations, and Future Directions},
  journal = {Biomolecules},
  year = {2025},
  doi = {10.3390/biom15070940}
}
Kostenlos starten →